Skip to content
Abstracts Logo
  • Home
  • Meetings Archive
  • Browse By Category
  • Browse By Keyword
  • Search
  • Home
  • Meetings Archive
  • Browse By Category
  • Browse By Keyword
  • Search
  • Home
  • Meetings Archive
  • Browse By Category
  • Browse By Keyword
  • Search
  • Home
  • Meetings Archive
  • Browse By Category
  • Browse By Keyword
  • Search
Search2020-05-20T12:01:36-05:00
Search
Search by Abstract Number, Title, Keyword, or Authors
Category
Sub-Category

(Optional)

Session Type
Meeting
Search Results for Naloxone
Oral Presentations
DECREASING RISK OF OPIOID OVERDOSES IN HOSPITALIZED PATIENTS
Hospital Medicine 2020, Virtual Competition
Background: There were approximately 46,000 opioid overdose deaths in 2017. It is known that opioid overdose risk is increased in patients with a diagnosis of substance use disorder, prior opioid overdose, and high suspicion of risk as assessed by clinical teams. The Risk Index for Overdose or Serious Opioid-Induced Respiratory Depression (RIOSORD) is a validated […]
Abstract Number: 174
NALOXONE AVAILABILITY IN NEW MEXICO
Hospital Medicine 2020, Virtual Competition
Background: New Mexico has a long-standing history of implementing harm reduction strategies for the prevention of opioid overdose. Most recently, on June 14, 2019, SB221 added language to the New Mexico Pain Relief Act requiring health care providers prescribing opioid analgesics for 5 days or longer to co-prescribe an opioid antagonist along with written information […]
Abstract Number: 224
COMBATING THE OPIOID EPIDEMIC THROUGH A NALOXONE BEST PRACTICE ALERT AND OTHER QUALITY IMPROVEMENT INTERVENTIONS WITHIN AN ACADEMIC HOSPITAL
Hospital Medicine 2020, Virtual Competition
Background: Drug overdose deaths involving opioids are on the rise in the setting of the current opioid epidemic in the United States (US).1 In 2017 there were ~46.6 drug overdose deaths a day in the US involving prescription opioids.1 Naloxone is a proven and effective opioid antagonist that is FDA approved for use in the […]
Abstract Number: 262
A RETROSPECTIVE STUDY OF NALOXONE ADMINISTRATION IN POTENTIAL OVERDOSE CASES IN A HOSPITAL EMERGENCY
Hospital Medicine 2020, Virtual Competition
Background: Background Fatalities caused by drug-overdose have increased in recent years across the US and are now the leading cause of injury-related death in the United States. Drug related deaths with cointoxicants are being seen more often and the increase in prevalence of opioid overdoses with possible concomitant medication use is a public health concern […]
  • This Week

  • This Month

  • All Time

  • This Week

  • Itching for a Heart Attack
  • Bc Powder Causing Intracerebral Bleed: Pitfalls of Overlooking Dosage of Seemingly Innocuous Otc Formulations
  • PECULIAR PRESENTATION OF VERTIGO IN HYPOTHYROIDISM
  • “Weight Loss or Brain Loss?”: Long Term Use of Phentermine Possibly Increases Risk for Ischemic Stroke
  • Cellulitis or DVT: Do Any Clinical Features Help to Differentiate
  • This Month

  • Itching for a Heart Attack
  • Bc Powder Causing Intracerebral Bleed: Pitfalls of Overlooking Dosage of Seemingly Innocuous Otc Formulations
  • EVERY RED IS NOT CELLULITIS: DEPENDENT RUBOR RARE BUT CLASSICAL FINDING OF SEVERE ARTERIAL INSUFFICIENCY
  • “Weight Loss or Brain Loss?”: Long Term Use of Phentermine Possibly Increases Risk for Ischemic Stroke
  • A Newborn with Bilateral Shoulder Dimples: Case Report and a Review of Literature
  • All Time

  • A Newborn with Bilateral Shoulder Dimples: Case Report and a Review of Literature
  • Cellulitis or DVT: Do Any Clinical Features Help to Differentiate
  • Bc Powder Causing Intracerebral Bleed: Pitfalls of Overlooking Dosage of Seemingly Innocuous Otc Formulations
  • “Weight Loss or Brain Loss?”: Long Term Use of Phentermine Possibly Increases Risk for Ischemic Stroke
  • A Case of Jamaican Stone
© Society of Hospital Medicine | All Rights Reserved
Go to Top